Cargando…

Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers

BACKGROUND: The term uterine smooth muscle tumor of uncertain malignant potential (STUMP) indicates a rare, equivocal entity between benign leiomyomas and leiomyosarcomas. In the present study, we evaluated a comprehensive range of clinical, surgical, and pathological features in a large multicenter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borella, Fulvio, Cosma, Stefano, Ferraioli, Domenico, Ray-Coquard, Isabelle, Chopin, Nicolas, Meeus, Pierre, Cockenpot, Vincent, Valabrega, Giorgio, Scotto, Giulia, Turinetto, Margherita, Biglia, Nicoletta, Fuso, Luca, Mariani, Luca, Franchi, Dorella, Vidal Urbinati, Ailyn Mariela, Pino, Ida, Bertschy, Gianluca, Preti, Mario, Benedetto, Chiara, Castellano, Isabella, Cassoni, Paola, Bertero, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Gynecologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640445/ https://www.ncbi.nlm.nih.gov/pubmed/35976464 http://dx.doi.org/10.1245/s10434-022-12353-y

Ejemplares similares

Correction: Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
por: Borella, Fulvio, et al.
Publicado: (2022)

From Uterus to Brain: An Update on Epidemiology, Clinical Features, and Treatment of Brain Metastases From Gestational Trophoblastic Neoplasia
por: Borella, Fulvio, et al.
Publicado: (2022)

Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers
por: Borella, Fulvio, et al.
Publicado: (2022)

Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis
por: Borella, Fulvio, et al.
Publicado: (2020)

Update on Prognostic and Predictive Markers in Mucinous Ovarian Cancer
por: Borella, Fulvio, et al.
Publicado: (2023)

Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer
por: Scotto, Giulia, et al.
Publicado: (2021)

FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
por: Metovic, Jasna, et al.
Publicado: (2022)

Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
por: Turinetto, Margherita, et al.
Publicado: (2022)

Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review
por: Borella, Fulvio, et al.
Publicado: (2020)

Perineural Invasion in Vulvar Squamous-Cell Carcinoma Is an Independent Risk Factor for Cancer-Specific Survival, but Not for Locoregional Recurrence: Results from a Single Tertiary Referral Center
por: Micheletti, Leonardo, et al.
Publicado: (2021)

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options
por: Borella, Fulvio, et al.
Publicado: (2023)

Vaginosonography versus MRI in Pre-Treatment Evaluation of Early-Stage Cervical Cancer: An Old Tool for a New Precision Approach?
por: Vidal Urbinati, Ailyn M., et al.
Publicado: (2022)

Fertility-Sparing Treatment for Endometrial Cancer: Oncological and Obstetric Outcomes in Combined Therapies with Levonorgestrel Intrauterine Device
por: Pino, Ida, et al.
Publicado: (2022)

Sparing Is Caring: Hormonal Retreatment in Women with Recurrent Endometrial Cancer after Fertility Preservation Management—A Single Centre Retrospective Study
por: Pino, Ida, et al.
Publicado: (2023)

Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neoplasia2+ Recurrence
por: Iacobone, Anna Daniela, et al.
Publicado: (2021)

The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality
por: Turinetto, Margherita, et al.
Publicado: (2021)

Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts
por: Bertero, Luca, et al.
Publicado: (2021)

Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience
por: Tuninetti, Valentina, et al.
Publicado: (2023)

Which Risk Factors and Colposcopic Patterns Are Predictive for High-Grade VAIN? A Retrospective Analysis
por: Iacobone, Anna Daniela, et al.
Publicado: (2023)

Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center
por: Preti, Mario, et al.
Publicado: (2021)

Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
por: Giannone, Gaia, et al.
Publicado: (2020)

Osteomyelitis of the pubic symphysis caused by methicillin-resistant Staphylococcus aureus after vaginal delivery: a case report and literature review
por: Cosma, Stefano, et al.
Publicado: (2019)

COVID-19 and Breast Cancer: Analysis of Surgical Management of a Large Referral Center during the 2020–2021 Pandemic Period
por: Borella, Fulvio, et al.
Publicado: (2023)

Uterine smooth muscle tumour of uncertain malignant potential (STUMP): Where are we now?
por: Ganesan, Raji
Publicado: (2020)

Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Comprehensive Multidisciplinary Update
por: Tinelli, Andrea, et al.
Publicado: (2023)

Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling
por: Vissio, Elena, et al.
Publicado: (2019)

Primary Retroperitoneal Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Diagnostic Enigma
por: Hariprasad, Chinniahnapalya Pandurangaiah, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
por: Borella, Fulvio, et al.
Publicado: (2020)

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report
por: Johnson, Michael H., et al.
Publicado: (2015)

Ependymomas
por: Bertero, Luca, et al.
Publicado: (2022)

The “Sandwich” Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate–High- and High-Risk Endometrial Cancer
por: Ferrero, Annamaria, et al.
Publicado: (2022)

Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report
por: Zumstein, L., et al.
Publicado: (2023)

The lobular neoplasia enigma: management and prognosis in a long follow-up case series
por: Metovic, Jasna, et al.
Publicado: (2021)

Obstetric and neonatal outcomes after SARS‐CoV‐2 infection in the first trimester of pregnancy: A prospective comparative study
por: Cosma, Stefano, et al.
Publicado: (2021)

Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas
por: Conconi, Donatella, et al.
Publicado: (2021)

Acute abdomen with a parasitic smooth muscle tumor of uncertain malignant potential (STUMP) in pregnancy; a unique case report
por: Price, Hannah Louise, et al.
Publicado: (2022)

Maintenance of Genomic Stability in Mouse Embryonic Stem Cells: Relevance in Aging and Disease
por: Giachino, Claudia, et al.
Publicado: (2013)

Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process
por: Turinetto, Valentina, et al.
Publicado: (2017)

ETMR-07. DNA methylation profiling of a series of rare CNS embryonal tumors in children: diagnostic and clinical impact
por: Dell’Anna, Vito Andrea, et al.
Publicado: (2022)

Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery
por: Cosma, Stefano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6aj3ilgot5a7fldqb34q9olull